Literature DB >> 36115117

Late presenting partially displaced atrial septal closure device: Surgical vs percutaneous correction? A case report.

Mian Mustafa Kamal1, Abdul Ahad Sohail2, Mian Yasir Kamal3, Naveed A Pasha4, Syed Shahabuddin5, Hasanat Sharif6.   

Abstract

INTRODUCTION: Atrial Septal Defect (ASD) is one of the most common congenital cardiac defect. Even though surgical repair of ASD is the current method of choice but percutaneous device closure is rapidly gaining popularity as it is less invasive. Dislodgment and embolization of the device may occur requiring urgent surgical retrieval. CASE
PRESENTATION: We report a case of 54-years-old female patient with a history of ASD device closure 4 years ago, presenting with progressive shortness of breath for past 2 months. She had a partial dehiscence of an ASD device causing a residual ASD of 17 mm. She underwent urgent surgical repair of an ASD with a bovine pericardial patch without ASD device being explanted. CLINICAL DISCUSSION: Management of a dislodged ASD device may be percutaneous or surgical. Dislodged ASD devices that present months after deployment may become fibro-adhered to the site of embolization. Hence its retrieval can be challenging even via open surgical method. Our case describes a novel method to repair a residual ASD and prevent complications associated with dislodgement of device without completely explanting the device.
CONCLUSION: In this case, the late presentation of the patient with a partially dehisced device makes it a distinctive case with a novel way on how to treat such a presentation surgically, ensuring that the device doesn't embolize further causing fatal complications.
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  ASD closure device; Atrial Septal Defect (ASD); Bovine patch repair; Case report; Late presentation; Partially displaced ASD device

Year:  2022        PMID: 36115117      PMCID: PMC9568741          DOI: 10.1016/j.ijscr.2022.107626

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


  8 in total

1.  Percutaneous, minimally invasive retrieval of a dislodged and impacted device from the abdominal aorta, four months after closure of an atrial septal defect.

Authors:  Philipp Wagdi; Martin Kunz
Journal:  Am J Cardiol       Date:  2008-07-25       Impact factor: 2.778

2.  Removal of displaced and impacted ASD device after 4 years.

Authors:  R S Dhaliwal; H Singh; N Swami; V Srivastava
Journal:  Thorac Cardiovasc Surg       Date:  2009-05-20       Impact factor: 1.827

3.  Long term evaluation of electromechanical delay in patients with atrial septal defect after transcatheter closure.

Authors:  Ahmet Öz; Emre Aruğaslan; Tufan Çınar; Muhammed Keskin; Mert Ilker Hayıroğlu; Şahin Avşar; Mehmet Baran Karataş; Berat Arıkan Aydın; Koray Demir; Barış Güngör; Osman Bolca
Journal:  Int J Cardiovasc Imaging       Date:  2018-07-30       Impact factor: 2.357

4.  The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines.

Authors:  Riaz A Agha; Thomas Franchi; Catrin Sohrabi; Ginimol Mathew; Ahmed Kerwan
Journal:  Int J Surg       Date:  2020-11-09       Impact factor: 6.071

Review 5.  Infective endocarditis after device closure of atrial septal defects: Case report and review of the literature.

Authors:  Pascal Amedro; Camille Soulatges; Alain Fraisse
Journal:  Catheter Cardiovasc Interv       Date:  2016-09-19       Impact factor: 2.692

6.  ASD closure with the Amplatzer device.

Authors:  Horacio J Faella; Alberto M Sciegata; José L Alonso; Luis Jmelnitsky
Journal:  J Interv Cardiol       Date:  2003-10       Impact factor: 2.279

7.  Late Migration of Amplatzer Septal Occluder Device to the Descending Thoracic Aorta.

Authors:  Hyo-Hyun Kim; Gi-Jong Yi; Suk-Won Song
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2017-02-05

8.  Percutaneous Retrieval of Embolized Amplatzer Septal Occluder after Treatment of Double Atrial Septal Defect: A Case Report.

Authors:  Jae Yeong Cho; Kye Hun Kim; Hyun Ju Yoon; Hyun Ju Seon; Youngkeun Ahn; Myung Ho Jeong; Jeong Gwan Cho; Jong Chun Park
Journal:  J Korean Med Sci       Date:  2015-08-13       Impact factor: 2.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.